SKILARENCE cpr 120 mg 90 pce

7680667030027 CH-66703 L04AX07 10.03.0.

Active substances:

SKILARENCE cpr 120 mg 90 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6670302
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
dimethylis fumaras 120 mg, lactosum monohydricum 144 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, simeticonum, E 132, E 171, natrii hydroxidum, pro compresso obducto corresp. natrium 1.94 mg.

Articles (1)

Skilarence 120mg, magensaftresistente Tablette
Tablette
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/10/2024
Patient information leaflet
Français
16/10/2024
Patient information leaflet
Italien
16/10/2024
Professional SmPC
Allemand
16/10/2024
Professional SmPC
Français
16/10/2024
Professional SmPC
Italien
16/10/2024

Detailed composition

Substance Quantity Type Category
dimethylis fumaras
120.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
144.0 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polysorbatum 80
- Substance HNIDK
talcum
- Substance HNIDK
triethylis citras
- Substance HNIDK
simeticonum
- Substance HNIDK
E 132
- Substance FIMDK
E 171
- Substance FNIDK
natrii hydroxidum
- Substance HNIDK
natrium
1.94 MG Substance HBESI

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
66703
Drug name
Skilarence, magensaftresistente Tablette
Galenic form
MATB
ATC Code
L04AX07
Authorization status
Z
Dispensation category
B
First authorization
28/01/2019
Authorization expiration date
31/12/9999
IT number
10.03.0.
Domain
Human medicine
Field of application
Behandlung von Hautmanifestationen bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis

Packaging details

Description (FR)
SKILARENCE cpr 120 mg 90 pce
Description (DE)
SKILARENCE Tabl 120 mg 90 Stk
Market launch
28/01/2019
Narcotic (BTM)
No

Available generics

Dimethylfumarat Accord, magensaftresistente Hartkapseln
CHF 101.60
View
Dimethylfumarat Accord, magensaftresistente Hartkapseln
CHF 357.05
View
Dimethylfumarat Accord, magensaftresistente Hartkapseln
CHF 1038.40
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
CHF 113.05
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
CHF 403.05
View
Dimethylfumarat-Mepha Teva, magensaftresistente Hartkapseln
CHF 1176.35
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
CHF 113.05
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
CHF 403.05
View
Dimethylfumarat Sandoz, magensaftresistente Hartkapseln
CHF 1176.35
View
Dimethylfumarat Spirig HC, magensaftresistente Hartkapseln
CHF 101.60
View

Other packaging sizes

SKILARENCE cpr 30 mg 42 pce
42 TABL
View
SKILARENCE cpr 120 mg 180 pce
180 TABL
View
Buy us a coffee Explore the data